如何提高慢性髓性白血病的无治疗缓解资格?
Alessandro Costa1, Massimo Breccia2
1Hematology Unit, Department of Medical Sciences and Public Health, Businco Hospital, University of Cagliari, Cagliari, Italy.
British journal of haematology
|December 27, 2023
概括
在慢性髓性白血病 (CML) 中实现无治疗缓解 (TFR) 允许停止氨酸激酶抑制剂 (TKI) 治疗. 改善患者选择和增强分子反应的策略是提高成功TFR率的关键.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 无治疗缓解 (TFR) 是治疗慢性髓性白血病 (CML) 的关键目标.
- 在保持深度分子响应 (DMR) 的同时,停止使用氨酸激酶抑制剂 (TKIs) 对一些患者是可以实现的.
- 早期研究显示TFR率为40-50%,大多数病例在六个月内复发.
研究的目的:
- 审查可以提高CML患者TFR资格的治疗策略.
- 讨论优化TFR的当前和潜在的未来方法.
- 确定影响成功TFR和患者选择的因素.
主要方法:
- 审查现有的临床试验数据和关于CML中TFR的科学文献.
- 对成功的TFR预后因素的分析.
- 讨论旨在改善分子反应的治疗干预措施.
主要成果:
- 对于TFR的关键预后因素包括治疗持续时间,DMR持续时间,风险得分和转录类型.
- 早期干预切换,治疗组合和剂量优化等策略可能会改善分子反应.
- 没有DMR的积极管理和诱导维护方法是TFR资格的潜在增强者.
结论:
- 优化患者选择和采用特定的治疗策略可以增加成功TFR的可能性.
- 需要对新方法进行进一步的研究,以最大限度地提高TFR资格和CML的结果.
- 增强分子反应对于实现持续的TFR和实现TKI停止至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


